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Abstract 
An 18 year old man underwent liver transplantation due to an Abernethy malformation associated with 
multiple hepatocellular nodules including one which was a rapidly enlarging and was suspicious for 
malignant transformation. Analysis of the explanted liver showed a spectrum of multiple hepatocellular 
nodules ranging in appearance from focal nodular hyperplasia, hepatocellular adenoma and to a well 
differentiated hepatocellular neoplasm borderline for hepatocellular carcinoma.  Mutational analysis 
revealed wildtype beta-catenin expression in the background liver and some nodules, whilst different 
variants were present in other lesions irrespective of their morphological appearance. No telomerase 
reverse transcriptase (TERT) promoter mutation was identified.  
Conclusion:  Abernethy malformations can lead to independent genetic events which can result in 
beta-catenin mutations associated with malignant transformation of hepatocellular nodules.  When 
following up such patients one must therefore have a high index of suspicion, particularly if 
radiological surveillance reveals a change in the nature of hepatic lesions. 
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Introduction 
Abernethy malformation is the eponym applied to congenital extrahepatic portosystemic shunts, a 
rare anatomical abnormality in which the splanchnic venous flow bypasses the liver and drains 
directly into the systemic venous circulation.  These malformations are commonly associated with 
other congenital abnormalities, such as polysplenia and congenital heart defects.  They can also lead 
to complications including liver dysfunction, hepatic encephalopathy, and the development of 
hepatocellular nodules ranging from focal nodular hyperplasia to hepatocellular carcinoma [1,2]  
 
The following case illustrates the occurrence of a spectrum of hepatocellular nodules in the context of 
an Abernethy malformation in an 18 year old man.  Molecular analysis of these lesions revealed 
different beta-catenin mutations, an occurrence associated with malignant transformation of 
hepatocellular adenoma [3].  This case highlights the potential of such lesions to undergo malignant 
transformation and the importance of having a high index of suspicion during their follow-up. 
 
 
Case Report 
An 18 year old man was under our care, with multiple nodular hepatic lesions secondary to type 1 
Abernethy malformation.  The diagnosis was made whilst investigating this young man for abnormal 
liver function tests but, in hindsight, suspicion regarding his vascular anatomy was raised as an infant 
when undergoing valvotomy for congenital pulmonary stenosis; the percutaneous procedure was 
converted to open due to difficulty proceeding through the inferior vena cava.  There is no other 
significant medical history. The patient was not obese or diabetic.  
He was investigated with magnetic resonance imaging (MRI) scan which demonstrated multiple 
hypervascular nodules in both lobes of the liver (fig1 image  a). The two dominant nodules inferiorly in 
segments 5/6 (fig 1 image b) measured 5 cms and 6 cms.  There was absence of intrahepatic portal 
vein with the main portal vein draining into the retrohepatic vena cava (fig 1 image c).  A further follow 
up MRI 3 months later demonstrated an increase in the size of the dominant segment 5 nodule from 6 
cm to 8 cm (fig 1 image d). 
This finding and deteriorating liver function precipitated the decision to perform an orthotopic liver 
transplant.  The explanted liver weighed 1,330g, the portal vein was identified but its branches could 
not be followed through into the hepatic parenchyma.  The background liver showed a range of 
changes affecting the small intrahepatic branches of the portal vein ranging from obliteration, 
attenuation of their profile, disarray or absence of the muscle wall.  .  Associated changes included 
ectasia of inlet venules and areas of sinusoidal dilatation, porto-septal fibrosis, parenchymal atrophy, 
hepatic plate disarray and in places nodular regenerative hyperplasia.  Focal deposits of copper-
binding protein were present at the limiting plate and there was a minimal degree of hepatocellular 
siderosis.  Seven principal hepatocellular nodules were present; they had a tan cut surface and 
ranged in size from 10mm to 80mm.  Multiple scattered nodules measuring up to 1mm were also 
present.  Histologic examination revealed some of the nodules to have features of focal nodular 
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hyperplasia (FNH), others hepatocellular adenoma (HCA), and one of the largest, corresponding to 
the one which had increased in size, some atypical features and in particular focal loss of reticulin 
staining. This lesion also showed pseudogland formation as well as intralesional congestion, 
telangiectasia and peliosis in places along with some haemorrhage which may have contributed to the 
interval size change.  There was no definite evidence of malignancy, however. The overall 
appearance, was short of overt hepatocellular carcinoma and the tumour was best classified as a well 
differentiated hepatocellular lesion [4] [fig 2].  All the lesions had a low proliferative rate and mitotic 
figures were not identified.   
 
On immunohistochemistry, beta-catenin expression was confined to the membrane of lesional cells 
with no evident nuclear expression in any of the lesions.  Glutamine synthetase expression was 
variable and ranged from map-like, to patchy and diffuse. One other lesion, with a diffuse glutamine 
expression pattern, also showed a perilesional rim of glutamine synthetase positive non-lesional 
hepatocytes.   Fatty acid binding protein expression was preserved in all lesions tested. The serum 
amyloid A expression was focal in some of the lesions and confined to the lesional hepatocytes facing 
the supporting stroma or the peliotic areas, but was not sufficient to characterise these lesions as 
inflammatory adenomas.  Immunohistochemistry for c-reactive protein did not show a significant 
overexpression in comparison with the background liver in most lesions.  The HCA-like lesions 
showed a diffuse pattern of sinusoidal staining with CD34, whereas this staining was more patchy in 
the FNH-like areas. There was no staining for glypican-3 in any of the lesions tested.  
 
Beta-catenin gene (CTNNB1) analysis was performed by PCR and sequencing of exons 2-4, 7 and 8 
using DNA extracted from frozen tissue from six of the principal nodules (one extraction from each) 
and the background liver (two extractions).  The background liver showed only wildtype sequence, 
whilst five of the nodules exhibited changes in exon 3: four a c.413T>C (p.Ser45Pro) change and one 
a c.414C>T (p.Ser45Phe) change. The final nodule carried a change in exon 7, c.1004A>T 
(p.Lys335Ile).  No mutations in exon 8 were identified. The exon 3 variants occur at a casein kinase I 
phosphorylation site, which are known to be pathogenic and have previously been reported in a 
variety of tumour types, including HCC (http://omim.org/entry/116806#0013). Exons 7 and 8 of the 
beta-catenin gene have recently been reported to contain additional mutation hotspots for HCA, and 
potentially HCC, development. The presence of separate nodules, each with a different form of Beta-
catenin protein (wild type, p.Ser45Pro, p.Ser45Phe, or p.Lys335Ile) on a background of wildtype liver 
suggests several independent genetic events have occurred in this liver and that a risk of neoplastic 
progression for some of these lesions exists independent of their histological appearance.  Table 1 
describes the histological features, immunohistochemical profile and beta-catenin mutation status of 
the lesions observed. No mutation in the telomerase reverse transcriptase (TERT) promoter mutation 
was identified. 
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Discussion 
This case report is the first to demonstrate hepatocellular nodules with different beta-catenin 
mutations arising on a background of Abernethy malformation.  Beta-catenin mutations are 
considered to be a risk factor for malignant transformation of HCA to HCC and it is therefore important 
to consider the possibility of such an event when monitoring people with Abernethy malformation.[3,5] 
 
Abernethy malformations are congenital extrahepatic portosystemic shunts, which can be further 
classified using the anastomotic pattern between the portal and systemic veins.  Type 1 exhibit 
complete absence of intrahepatic portal venous branches (end-to-side shunt) and can also be known 
as congenital absence of the portal vein.  In type 2 there is preservation of intrahepatic venous supply 
but some portal flow is diverted through a side-to-side shunt into a systemic vein. [6]  
 
Patients with type 1 malformations have a female predominance (74%) and typically present early in 
life with associated congenital abnormalities which can be intra-abdominal or cardiac.[1,6]  Those with 
type 2 malformations are less likely to be affected by concomitant congenital defects and tend to 
present later in life with no sex preference.[1]  The diagnosis of Abernethy malformation is often made 
when investigating infants and children for non-specific liver dysfunction and its sequelae, including 
hypoglycaemia, hyperammonaemia, hepatic encephalopathy, and portopulmonary hypertension.[1,6]  
Imaging studies are diagnostic but liver biopsies may be used to supplement these modalities as 
histology may reveal changes to small portal vein branches or associated secondary parenchymal 
changes which would be indicative of an underlying anomaly of the vascular supply.[6]
 
Approximately 50% of cases of Abernethy malformation are associated with hepatocellular nodules, 
ranging from FNH to HCC.  A similar association has been described with other hepatic vascular 
disorders. [2,6] A recent retrospective multicentre survey of hepatic vascular disorders with 
associated well differentiated hepatocellular nodules highlighted the need to consider these lesions as 
potentially different from the conventional ones arising in association with oral contraceptives use.  
Such lesions are likely to have a different pathogenesis and natural history, and greater risk of 
malignant transformation.[2] 
 
Beta-catenin is an adherens junction protein involved in the Wnt signalling pathway, it is encoded by 
the 16 exon CTNNB1 gene at 3p22.1, (http://omim.org/entry/116806#0013).  Disruption of beta-
catenin phosphorylation prevents degradation of the molecule causing constitutive activation of 
various TCF/LEF transcription factors and is associated with several malignancies 
(http://omim.org/entry/116806#0013).[3]  HCAs with beta-catenin mutations are considered to be at 
risk of malignant transformation when compared to other subtypes and have been identified in HCCs. 
[3,7]  Indeed, the three beta-catenin variants found in these hepatocellular nodules, c.413T>C 
(Ser45Pro), c.414C>T (Ser45Phe) and c.1004A>T (Lys335Ile) have previously been identified in a 
series of HCAs and HCCs.[7,8] 
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There are two particular aspects that need to be considered in this case.  The first one is the 
occurrence of different types of beta-catenin mutation in the hepatocellular nodules but not in the 
background liver.  Whether nodule formation related to the underlying vascular anomaly precedes the 
onset of beta-catenin mutation or the mutation precedes nodule development remains uncertain.  
Systemic shunting of blood causes non-specific liver disturbance due to the unbalanced regional 
blood flow and arterialisation.  It is thought that this leads to relative hepatic ischaemia and 
compensatory increase in hepatic arterial flow, in addition to altered exposure of hepatocytes to 
hormones and growth factors.[6]These factors could lead to abnormal liver development, function and 
regeneration and could provide a stimulus to tumour development.[6]
 
 
The second aspect is that the beta-catenin mutations have occurred in nodules of different types 
including those resembling focal nodular hyperplasia histologically. Interestingly, transcriptome 
analysis of FNH has demonstrated activated hypophosphorylated beta-catenin protein accumulated in 
the absence of activating mutations.[9]  The larger of the two lesions in this case report had an 
increase pattern of glutamine synthetase expression which deviated from the typical map-like one 
described by Bioulac-Sage et al.[10] and which could provide a clue to an underlying abnormality of 
the beta-catenin pathway.  This supports the idea that hepatocellular lesions developing in the context 
of Abernethy malformation should be considered at risk of malignant progression independent of their 
size, histological and possibly radiological appearance, and that these patients should be followed up 
very closely.  The multifocal nature of these lesions and genotypic heterogeneity indicate a field 
change, and emphasises the role of liver transplantation as a curative method in comparison with 
surgical resection targeted to more suspicious lesions.   
 
 
Conclusion 
This case report demonstrates that discrete beta-catenin mutations associated with malignant 
transformation can occur in hepatocellular nodules arising on a background of Abernethy 
malformation, independent of their size and histological appearance.  The precise etiology is unclear, 
but may be common to other hepatic vascular disorders.  It is therefore important to consider the 
possibility of malignant transformation of hepatocellular nodules when monitoring patients with 
Abernethy malformation, institute proper and close follow-up protocols and consider liver 
transplantation at a relatively early stage. 
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Figure 1:  Imaging of the liver 
 
Figure 1. MRI scan arterial phase images  (A &B) demonstrating multiple hypervascular nodules in 
both lobes of the liver with a dominant nodule in segment 5 (arrow). Venous phase MR (C) depicting 
large porto-caval shunt (block arrow) and absence of intrahepatic portal venous branches. Follow up 
MR 3 months later (D) demonstrating an increase in the size of the dominant lesion in segment 5 
(arrow). 
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Figure 2:  Photomicrographs representative of the background liver and nodular lesions 
   
A      B 
   
C      D 
 
A:  Background liver showing changes affecting the small intrahepatic branches of the portal vein 
including from obliteration, attenuation of their profile, and disarray of their muscle coat.  Associated 
changes seen include ectasia of inlet venules and areas of sinusoidal dilatation, porto-septal fibrosis, 
parenchymal atrophy, and hepatic plate disarray. 
B:  Focal nodular hyperplasia (tumour 2). 
C:  Hepatocellular adenoma (tumour 1). 
D:  Well differentiated hepatocellular neoplasm (tumour 6) exhibiting some atypical features and 
pseudogland formation as well as intralesional congestion, telangiectasia and peliosis with focal 
haemorrhage which may have contributed to the interval size change.   
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Table 1:  Beta-catenin (CTNNB1 exons 2-4, 7 and 8) histological mutational analysis 
Tissue 
Nodu
le 
size 
Histologic
al 
Phenotype 
Immunohistochemical Profile 
Variant Status 
   Beta Cat GS SAA CRP FABP CD34 Glypica
n-3 
Reticuli
n 
  
Backgrou
nd liver 
 Changes 
affecting 
small 
intrahepatic 
branches of 
the portal 
vein 
Membrano
us 
Norm
al 
patter
n 
Norm
al 
patter
n 
Normal 
pattern 
Preserv
ed 
Normal 
pattern 
No 
staining 
Normal None 
detected 
Norma
l only 
detect
ed 
Tumour 1   6 cm Hepatocellu
lar 
adenoma 
Membrano
us, focal 
cytoplasmi
c. No 
nuclear 
staining 
Diffus
e 
Focal Similar to 
background 
liver 
Preserv
ed 
Diffuse 
sinusoid
al 
staining 
No 
staining 
Preserv
ed 
c.413T>C; 
p.(Ser45Pr
o) 
Variant 
and 
normal 
detect
ed 
Tumour 2   1 cm Focal 
nodular 
hyperplasia 
Membrano
us. No 
nuclear 
staining 
Patch
y 
Focal Similar to 
background 
liver 
Preserv
ed 
Patchy 
sinusoid
al 
No 
staining 
Preserv
ed 
c.414C>T; 
p.(Ser45P
he) 
Variant 
and 
normal 
detect
ed 
Tumour 3 1 cm Focal 
nodular 
hyperplasia 
Membrano
us. No 
nuclear 
staining 
Map-
like 
Focal Similar to 
background 
liver 
Preserv
ed 
Patchy 
sinusoid
al 
No 
staining 
Preserv
ed 
c.1004A>T
; 
p.(Lys335Il
e) 
Variant 
and 
normal 
detect
ed 
Tumour 4 1.5 
cm 
Focal 
nodular 
hyperplasia 
Membrano
us, focal 
cytoplasmi
c. No 
nuclear 
staining 
Patch
y 
Focal Similar to 
background 
liver 
Preserv
ed 
Patchy 
sinusoid
al, 
focally 
diffuse 
No 
staining 
Preserv
ed 
c.413T>C; 
p.(Ser45Pr
o) 
Variant 
and 
normal 
detect
ed 
Tumour 5 2 cm Hepatocellu
lar 
adenoma 
Membrano
us, focal 
cytoplasmi
Diffus
e 
Focal Similar to 
background 
liver 
Preserv
ed 
Patchy 
sinusoid
al, 
No 
staining 
Preserv
ed 
c.413T>C; 
p.(Ser45Pr
o) 
Variant 
and 
normal 
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c. No 
nuclear 
staining 
focally 
diffuse 
detect
ed 
Tumour 6 8 cm Well 
differentiate
d 
hepatocellu
lar 
neoplasm* 
Membrano
us. No 
nuclear 
staining 
Patch
y 
Focal Focally 
overexpress
ed 
Preserv
ed 
Diffuse No 
staining 
Focal 
loss 
c.413T>C; 
p.(Ser45Pr
o) 
Variant 
and 
normal 
detect
ed 
Two DNA extractions on background liver were performed and one extraction each from the 6 tumours. 
*Tumour 6 was radiologically suspicious for transformation into hepatocellular carcinoma in part due to relatively rapid enlargement.  Histologically, 
this lesion had some atypical features but fell short of an overt hepatocellular classification and is best classified as well differentiated 
hepatocellular neoplasm.  The interval enlargement was explained by intralesional haemorrhage. 
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Figure 1 
